secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2026-05-11T23:59:59+00:00
Accession:  0001682852-26-000101
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna amends bylaws for federal forum exclusivity; stockholders re-elect directors
--------------------------------------------------------------------------------

- Board approved bylaw amendment designating federal district courts as exclusive forum for Securities Act claims, effective immediately.
- Stockholders re-elected Sandra Horning, M.D. and Abbas Hussain as Class II directors for three-year terms.
- Say-on-pay advisory vote passed with 169M for, 90.8M against; company will hold annual advisory votes.
- Ratification of Ernst & Young as independent auditor for FY 2026 approved with 298.8M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285226000101/0001682852-26-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285226000101/mrna-20260506.htm
  HTML page:      https://secwatch.observer/filing/0001682852-26-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer